Clinicopathological features and treatment strategy for triple-negative breast cancer.

International Journal of Clinical Oncology
Yutaka Yamamoto, Hirotaka Iwase

Abstract

Breast cancers are divided into at least 4 subtypes on the basis of gene expression profiles and expression of receptors (hormone receptors (HR) and HER2) as measured by immunohistochemistry. These subtypes have different prognoses and responses to treatments such as endocrine manipulation, anti-HER2 therapy, and chemotherapy. Triple-negative breast cancer (TNBC) is immunohistochemically defined as lacking estrogen and progesterone receptors and not overexpressing HER2. TNBC accounts for approximately 15% of breast cancer patients, and is more chemosensitive but has a worse prognosis than the HR-positive/HER2-negative phenotype. TNBC is a heterogeneous disease that does not offer specific targets in the same way as HR-positive and HER2-positive breast cancers, and is similar to basal-like breast cancer and BRCA1-related breast cancer. At present, the lack of highly effective therapeutic targets for TNBC leaves standard chemotherapy, for example the combination of anthracycline and taxane, as the only medical treatment, but this is insufficiently efficacious. Novel approaches for TNBC, for example DNA damaging agents, PARP-1 inhibitors, receptor tyrosin kinase inhibitors (TKIs), and antiangiogenesis agents, have been examined in...Continue Reading

References

Oct 7, 1994·Science·P A FutrealY Miki
Aug 24, 1999·The Biochemical Journal·D D'AmoursG G Poirier
Aug 30, 2000·Nature·C M PerouD Botstein
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Aug 6, 2002·Journal of Medical Genetics·P O ChappuisW D Foulkes
Jun 6, 2003·The New England Journal of Medicine·Richard Wooster, Barbara L Weber
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Torsten O NielsenCharles M Perou
Oct 29, 2004·Nature Reviews. Cancer·Nicholas TurnerAlan Ashworth
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roman RouzierLajos Pusztai
Dec 13, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Chad A LivasyCharles M Perou
Feb 14, 2006·Cancer Cell·Andrea L RichardsonShridar Ganesan
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Lisa A CareyRobert C Millikan
Oct 4, 2006·Oncogene·N C TurnerA N Tutt
Nov 23, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce G HafftyDeborah Toppmeyer
Dec 6, 2006·Cancer·Emad A RakhaIan O Ellis
Jan 16, 2007·Breast Cancer Research : BCR·Laura G FulfordSunil R Lakhani
Apr 18, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lisa A CareyCharles M Perou
Jun 21, 2007·Breast Cancer Research and Treatment·Robert C MillikanCharles M Perou
Jul 26, 2007·BMC Cancer·Marc TischkowitzWilliam D Foulkes
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca DentSteven A Narod
Aug 7, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F-C BidardF André
Sep 20, 2007·Breast Cancer Research and Treatment·Masakazu ToiUNKNOWN Japan Breast Cancer Research Group (JBCRG)
Sep 22, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Enrique LermaAgustí Barnadas
Oct 9, 2007·Breast Cancer Research and Treatment·David S P TanJorge S Reis-Filho
Oct 12, 2007·The New England Journal of Medicine·Daniel F HayesUNKNOWN Cancer and Leukemia Group B (CALGB) Investigators
Jan 4, 2008·Histopathology·J S Reis-Filho, A N J Tutt
Jan 17, 2008·Current Opinion in Obstetrics & Gynecology·Soonmo Peter KangLyndsay N Harris
Feb 6, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cornelia LiedtkeLajos Pusztai
Feb 21, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marianne KyndiUNKNOWN Danish Breast Cancer Cooperative Group
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maggie C U CheangTorsten O Nielsen

❮ Previous
Next ❯

Citations

Oct 4, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H Joensuu, J Gligorov
Jan 12, 2012·Breast Cancer Research and Treatment·Mev Dominguez ValentinYves-Jean Bignon
Oct 16, 2015·Molecular Medicine Reports·Chung-Hsin TsaiYi-Ming Shyr
Oct 31, 2014·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Marie-Kristin von WahldeChristof Bernemann
Jul 16, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V AdamoM Venturini
Sep 26, 2013·The Breast : Official Journal of the European Society of Mastology·Roxana ChioreanIoana Berindan-Neagoe
Jan 29, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Debora de Melo GagliatoMariana Chavez-Macgregor
Mar 5, 2013·Applied Immunohistochemistry & Molecular Morphology : AIMM·Harold C SullivanCynthia Cohen
May 24, 2019·Breast Cancer Research and Treatment·Maria K PomponioJulia C Tchou
Nov 30, 2016·Iranian Journal of Radiology : a Quarterly Journal Published by the Iranian Radiological Society·Yu-Mee SohnMirinae Seo
Aug 9, 2020·Cancer Medicine·Demetria Smith-GrazianiMariana Chavez-MacGregor
Jun 29, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ai-Na LiuLiang-Ming Zhang
May 20, 2020·Breast Cancer : Basic and Clinical Research·Fatima Zahra MouhMariam Amrani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
O GluzN Harbeck
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
William J Irvin, Lisa Carey
© 2021 Meta ULC. All rights reserved